O'Brien P Q, Stevens L M, Chen K W. "Method for the Synthesis of 3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamido)-3-methylpyridin-2-yl)benzoic acid hydrochloride" [P]. US Patent, US 9958992 B2, 2019-07-01.
Schröder R, Klinger H, Lee S K. "A Process for Preparing High-Purity 3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamido)-3-methylpyridin-2-yl)benzoic acid hydrochloride" [P]. US Patent, US 9748010 B2, 2021-10-16.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 2039, 2906-2934.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2016, 1941, (1), 3762-3765.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamido)-3-methylpyridin-2-yl)benzoic acid hydrochloride Using HRMS and NMR". Chemosphere, 2012, 1424, (11), 9069-9085.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2018, 1438, (8), 6436-6466.